Suprachoroidal Gene Delivery for Chorioretinal Diseases: Advancements, Potential and Challenges
Time: 11:30 am
day: Day One 11th
Details:
- Microinjector-based suprachoroidal (SC) gene delivery for minimally invasive office-based gene therapy
- SCS Microinjector®-based AAV gene therapy: Preclinical and clinical safety, efficacy, and durability
- Non-viral particle-based SC gene delivery for repeatable gene therapy
- Challenges and future direction
